Published in Nucleic Acids Res on August 15, 2003
The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 8.08
Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat Neurosci (2009) 3.47
Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. Genome Res (2005) 2.46
LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet (2011) 2.42
Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res (2012) 2.29
LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res (2006) 1.94
The take and give between retrotransposable elements and their hosts. Annu Rev Genet (2008) 1.86
A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res (2004) 1.59
All y'all need to know 'bout retroelements in cancer. Semin Cancer Biol (2010) 1.52
Mobile DNA elements in the generation of diversity and complexity in the brain. Nat Rev Neurosci (2014) 1.35
A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res (2005) 1.34
LINE dancing in the human genome: transposable elements and disease. Genome Med (2009) 1.33
Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proc Natl Acad Sci U S A (2006) 1.32
Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res (2013) 1.31
The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res (2004) 1.31
Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res (2009) 1.27
The impact of multiple splice sites in human L1 elements. Gene (2008) 1.26
The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition. PLoS Genet (2009) 1.18
Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. Cell Rep (2013) 1.18
Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol (2009) 1.15
Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol Genet Genomics (2003) 1.04
Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res (2011) 1.04
Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics (2011) 1.03
Poly(A) binding protein C1 is essential for efficient L1 retrotransposition and affects L1 RNP formation. Mol Cell Biol (2012) 0.99
Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. Front Microbiol (2012) 0.99
Defending the genome from the enemy within: mechanisms of retrotransposon suppression in the mouse germline. Cell Mol Life Sci (2013) 0.97
L1 retrotransposons, cancer stem cells and oncogenesis. FEBS J (2013) 0.97
Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night. Nucleic Acids Res (2014) 0.96
The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes. Microbiol Spectr (2015) 0.96
Expressing genes do not forget their LINEs: transposable elements and gene expression. Front Biosci (Landmark Ed) (2012) 0.94
Intronic L1 retrotransposons and nested genes cause transcriptional interference by inducing intron retention, exonization and cryptic polyadenylation. PLoS One (2011) 0.93
Roles for retrotransposon insertions in human disease. Mob DNA (2016) 0.92
The L1 retrotransposition assay: a retrospective and toolkit. Methods (2009) 0.92
Mutagenesis in rodents using the L1 retrotransposon. Genome Biol (2007) 0.92
The Fine LINE: Methylation Drawing the Cancer Landscape. Biomed Res Int (2015) 0.91
Response of transposable elements to environmental stressors. Mutat Res Rev Mutat Res (2015) 0.88
L1 expression and regulation in humans and rodents. Front Biosci (Elite Ed) (2012) 0.88
DNA damage and L1 retrotransposition. J Biomed Biotechnol (2006) 0.86
The impact of CpG island on defining transcriptional activation of the mouse L1 retrotransposable elements. PLoS One (2010) 0.86
How retrotransposons shape genome regulation. Curr Opin Genet Dev (2016) 0.85
Restless genomes humans as a model organism for understanding host-retrotransposable element dynamics. Adv Genet (2011) 0.84
The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells. EMBO J (2013) 0.84
Importance of RNA analysis in interpretation of reporter gene expression data. Anal Biochem (2011) 0.83
Dicer, a new regulator of pluripotency exit and LINE-1 elements in mouse embryonic stem cells. FEBS Open Bio (2017) 0.83
L1 retrotransposon-mediated stable gene silencing. Nucleic Acids Res (2005) 0.83
In vitro screening for compounds that enhance human L1 mobilization. PLoS One (2013) 0.81
An S/MAR-based L1 retrotransposition cassette mediates sustained levels of insertional mutagenesis without suffering from epigenetic silencing of DNA methylation. Epigenetics (2010) 0.80
Molecular epigenetic switches in neurodevelopment in health and disease. Front Behav Neurosci (2015) 0.80
Restricting retrotransposons: a review. Mob DNA (2016) 0.79
De novo LINE-1 retrotransposition in HepG2 cells preferentially targets gene poor regions of chromosome 13. Genomics (2014) 0.79
Is somatic retrotransposition a parasitic or symbiotic phenomenon? Mob Genet Elements (2011) 0.79
Do small RNAs interfere with LINE-1? J Biomed Biotechnol (2006) 0.79
The potential regulation of L1 mobility by RNA interference. J Biomed Biotechnol (2006) 0.77
Drawing a fine line on endogenous retroelement activity. Mob Genet Elements (2015) 0.76
Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition. Front Chem (2016) 0.75
Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma. Transl Neurosci (2015) 0.75
Conserved 3' UTR stem-loop structure in L1 and Alu transposons in human genome: possible role in retrotransposition. BMC Genomics (2016) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res (1995) 21.22
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74
Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell (1993) 8.99
High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21
Human LINE retrotransposons generate processed pseudogenes. Nat Genet (2000) 6.64
Biology of mammalian L1 retrotransposons. Annu Rev Genet (2001) 6.52
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A (1996) 6.29
Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A (2003) 6.16
Reverse transcriptase encoded by a human transposable element. Science (1991) 5.86
Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell (2002) 5.69
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell (2002) 5.07
Exon shuffling by L1 retrotransposition. Science (1999) 4.99
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A (1991) 4.96
Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet (1998) 4.01
Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol (1988) 3.99
Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol (1990) 3.58
Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J (1996) 3.34
AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics (1994) 3.02
The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J (2002) 2.99
Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol (2001) 2.88
Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol Cell Biol (1991) 2.88
Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci U S A (2003) 2.85
Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res (2000) 2.84
LINE-1: a mammalian transposable element. Biochim Biophys Acta (1987) 2.63
LINEs and Alus--the polyA connection. Nat Genet (1997) 2.58
Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon. EMBO J (1997) 2.52
Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics (2002) 2.49
A mouse model of human L1 retrotransposition. Nat Genet (2002) 2.39
Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol (2002) 2.31
A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A (2000) 2.31
Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci (2002) 2.25
An actively retrotransposing, novel subfamily of mouse L1 elements. EMBO J (1998) 1.99
LINE drive. retrotransposition and genome instability. Cell (2002) 1.92
Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res (2000) 1.69
Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev (2001) 1.69
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res (2001) 1.64
Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet (2002) 1.56
Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet (1993) 1.48
Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells (1999) 1.48
Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem (1999) 1.40
Identification of an internal cis-element essential for the human L1 transcription and a nuclear factor(s) binding to the element. Nucleic Acids Res (1992) 1.35
RUNX1/AML1: a central player in hematopoiesis. Int J Hematol (2001) 1.23
Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins. Mol Cell Biol (1997) 1.22
A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol (1996) 1.12
Environmental factors affecting transcription of the human L1 retrotransposon. I. Steroid hormone-like agents. Mutagenesis (2002) 0.98
Phylogenesis and regulated expression of the RUNT domain transcription factors RUNX1 and RUNX3. Blood Cells Mol Dis (2003) 0.93
Promoter binding proteins of an active human L1 retrotransposon. Biochem Biophys Res Commun (1993) 0.89
Gene repair and transposon-mediated gene therapy. Stem Cells (2002) 0.87
Runx3 is essential for the target-specific axon pathfinding of trkc-expressing dorsal root ganglion neurons. Blood Cells Mol Dis (2003) 0.84
Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1. Int Immunol (2001) 0.80
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature (2009) 9.15
Genomewide association study of leprosy. N Engl J Med (2009) 8.17
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol (2008) 7.86
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature (2003) 7.69
Genetics: influence of TOR kinase on lifespan in C. elegans. Nature (2003) 7.55
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59
Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A (2003) 6.16
Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet (2003) 5.51
High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res (2010) 5.38
Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science (2003) 5.19
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA (2004) 4.88
L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol (2006) 4.80
Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science (2005) 4.70
PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A (2003) 4.46
Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell (2008) 4.19
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature (2011) 4.07
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther (2007) 3.93
Mobile elements and mammalian genome evolution. Curr Opin Genet Dev (2003) 3.68
Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 3.60
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med (2004) 3.55
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature (2012) 3.44
The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur J Cancer (2012) 3.41
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One (2010) 3.38
Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res (2005) 3.34
RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A (2004) 3.25
Expanding window compressed sensing for non-uniform compressible signals. Sensors (Basel) (2012) 2.98
CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol Cell (2009) 2.79
On the origin of new genes in Drosophila. Genome Res (2008) 2.69
L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev (2009) 2.68
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord (2007) 2.68
PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell (2008) 2.68
Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res (2002) 2.64
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63
SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet (2003) 2.55
A mouse model of human L1 retrotransposition. Nat Genet (2002) 2.39
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res (2008) 2.35
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res (2009) 2.32
Mechanisms of microRNA deregulation in human cancer. Cell Cycle (2008) 2.30
Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res (2012) 2.29
The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun (2005) 2.25
Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes. J Cell Physiol (2007) 2.24
A homochiral porous metal-organic framework for highly enantioselective heterogeneous asymmetric catalysis. J Am Chem Soc (2005) 2.24
Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng (2010) 2.23
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood (2003) 2.21
ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg (2012) 2.18
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med (2003) 2.18
Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat (2007) 2.17
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res (2006) 2.15
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
FSIM: a feature similarity index for image quality assessment. IEEE Trans Image Process (2011) 2.13
HISTONE DEACETYLASE19 is involved in jasmonic acid and ethylene signaling of pathogen response in Arabidopsis. Plant Cell (2005) 2.06
L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet (2007) 2.04
Functional divergence of human cytoplasmic myosin II: kinetic characterization of the non-muscle IIA isoform. J Biol Chem (2003) 2.03
PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem (2006) 2.02
Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res (2011) 1.99
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol (2009) 1.97
Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection methods and descriptive analyses. Res Rep Health Eff Inst (2005) 1.95
Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet (2011) 1.95
Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res (2010) 1.94
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood (2012) 1.94
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med (2011) 1.88
Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem (2004) 1.88
The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell (2012) 1.84
PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology (2011) 1.82
Polysomnography performed in the unattended home versus the attended laboratory setting--Sleep Heart Health Study methodology. Sleep (2004) 1.81
Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells. Cancer Biol Ther (2003) 1.80
LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol (2007) 1.79
Subcortical origins of human and monkey neocortical interneurons. Nat Neurosci (2013) 1.78
Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res (2010) 1.78
Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord (2007) 1.77
Novel method for high-throughput phenotyping of sleep in mice. Physiol Genomics (2006) 1.77
Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol (2008) 1.76
L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A (2006) 1.73
The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci U S A (2007) 1.73
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol (2008) 1.72
HDA6 is required for jasmonate response, senescence and flowering in Arabidopsis. J Exp Bot (2008) 1.69
Identification and characterization of neuroblasts in the subventricular zone and rostral migratory stream of the adult human brain. Cell Res (2011) 1.67
EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell (2012) 1.65
AKT2 confers protection against aortic aneurysms and dissections. Circ Res (2012) 1.65
FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One (2013) 1.65
Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol (2005) 1.64
Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J (Engl) (2010) 1.62
Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun (2009) 1.60
PTEN regulates collagen-induced platelet activation. Blood (2010) 1.60
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res (2003) 1.58
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging (2008) 1.57
Neuropathic features in fragile X premutation carriers. Am J Med Genet A (2007) 1.56
Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet (2002) 1.56
Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res (2010) 1.56
p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut (2006) 1.56
TBestDB: a taxonomically broad database of expressed sequence tags (ESTs). Nucleic Acids Res (2007) 1.55
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models. Clin Cancer Res (2012) 1.53
A potential role for the nucleolus in L1 retrotransposition. Hum Mol Genet (2004) 1.53